Printers

CELLINK, providing researchers with affordable bioprinting technology

Recently, CELLINK, based in Boston, launched the BIO X6 bioprinting platform. This six-printhead bioprinting platform enables users to combine more materials, cells and tools than other systems currently available on the market. In fact, the company specialises in designing and&h

cellink
3Dnatives

Recently, CELLINK, based in Boston, launched the BIO X6 bioprinting platform. This six-printhead bioprinting platform enables users to combine more materials, cells and tools than other systems currently available on the market. In fact, the company specialises in designing and developing bioprinting technologies that enable to 3D print organs and tissue for applications in pharmaceuticals to cosmetics. They also offer a patent-pending bioink that allows human cells to grow and thrive as they would in their natural environment. Ultimately, the aim of the startup is to provide researchers with affordable bioprinting technology that can help to further their research. We spoke to CEO and Co-Founder Erik Gatenholm to learn more!

3DN: Can you tell us about yourself and your relationship with 3D printing technologies?

Erik Gatenholm

As the CEO and Co-founder of CELLINK, I have had a love for 3D printing technologies for over a decade. I knew this was a market I always wanted to get into. When I met my co-founder Hector Martinez, we realized a gap in the market when it came to purchasing bioinks. Together with our founding team, we commercialized the first universal bioink and then expanded to manufacturing 3D bioprinters and other technology used for bioprinting.

3DN: What is CELLINK’s primary mission?

Our mission is to provide researchers all around the world with affordable bioprinting technology that can help further their research. As I just explained, we saw a gap in the market for bioinks and shortly after learned that there was a way to democratize bioprinting technology. Our systems are now in over 600 labs in 60+ countries. Our team has grown to nearly 200 individuals in just 3 years. We continue to collaborate with leading researchers around the globe to improve our technology and develop new products to assist with their work.